QA: Rein Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420565_2021_Rein_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001420565, Rein Therapeutics Inc

  xvar xval
0 AssetsCurrent 16,326,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 15,000
3 remainder_Assets 0
4 LiabilitiesCurrent 3,960,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 219,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,452,028
9 ResearchAndDevelopmentExpense 8,653,489
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 587,000
13 remainder_ComprehensiveNetIncome -1,493
  yvar yval
0 Assets 16,341,000
1 Liabilities 4,179,000
2 Expenses 16,105,517
3 Revenues 0
4 StockholdersEquity 12,162,000
5 NetIncome -15,518,517
6 ComprehensiveNetIncome -15,519,264
7 BaseVar 18,607,005
8 EconomicCapitalRatiobeforeLimitedLiability 1.07
9 EconomicCapitalRatio 2.36

Edgar->Model Mapping

Feature Distribution

Change over Time